Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BDMD NASDAQ:MDAI NYSE:RVP NASDAQ:STSS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBDMDBaird Medical Investment$1.85-0.4%$2.10$0.76▼$7.26$76.59M-1.181.54 million shs107,875 shsMDAISpectral AI$2.27+0.7%$1.64$1.18▼$3.21$72.15M1.16588,973 shs93,164 shsRVPRetractable Technologies$0.71+0.2%$0.68$0.60▼$1.14$21.14M1.2556,384 shs6,731 shsSTSSSharps Technology$1.88+0.6%$1.77$1.42▼$18.23$72.89M2.03526,733 shs21,103 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBDMDBaird Medical Investment+4.49%+8.14%+1.64%+102.09%-65.23%MDAISpectral AI+1.35%+9.76%+37.20%+48.03%+93.97%RVPRetractable Technologies+1.15%+10.99%+1.45%+7.85%-7.03%STSSSharps Technology-0.53%+4.76%+19.87%+13.33%-59.87%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBDMDBaird Medical Investment$1.85-0.4%$2.10$0.76▼$7.26$76.59M-1.181.54 million shs107,875 shsMDAISpectral AI$2.27+0.7%$1.64$1.18▼$3.21$72.15M1.16588,973 shs93,164 shsRVPRetractable Technologies$0.71+0.2%$0.68$0.60▼$1.14$21.14M1.2556,384 shs6,731 shsSTSSSharps Technology$1.88+0.6%$1.77$1.42▼$18.23$72.89M2.03526,733 shs21,103 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBDMDBaird Medical Investment+4.49%+8.14%+1.64%+102.09%-65.23%MDAISpectral AI+1.35%+9.76%+37.20%+48.03%+93.97%RVPRetractable Technologies+1.15%+10.99%+1.45%+7.85%-7.03%STSSSharps Technology-0.53%+4.76%+19.87%+13.33%-59.87%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBDMDBaird Medical Investment 1.00SellN/AN/AMDAISpectral AI 2.00Hold$3.0032.45% UpsideRVPRetractable Technologies 0.00N/AN/AN/ASTSSSharps Technology 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest RVP, STSS, BDMD, and MDAI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/6/2026MDAISpectral AI Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)4/24/2026BDMDBaird Medical Investment Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)4/21/2026STSSSharps Technology Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/25/2026MDAISpectral AI BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$3.002/10/2026MDAISpectral AI BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$3.00(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBDMDBaird Medical Investment$22.54M3.37N/AN/AN/A∞MDAISpectral AI$19.65M3.67N/AN/A($0.19) per share-11.92RVPRetractable Technologies$38.27M0.55$0.01 per share48.25$3.31 per share0.21STSSSharps Technology$200K363.69N/AN/A$9.12 per share0.21Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBDMDBaird Medical InvestmentN/AN/AN/AN/AN/AN/AN/AN/AN/AMDAISpectral AI-$7.57M-$0.31N/AN/AN/A-41.11%N/A-35.64%5/12/2026 (Estimated)RVPRetractable Technologies-$7.01M-$0.42N/AN/AN/A-41.11%-17.15%-9.33%N/ASTSSSharps Technology-$282.50M-$831.83N/AN/AN/AN/A-145.56%-140.36%5/14/2026 (Estimated)Latest RVP, STSS, BDMD, and MDAI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2026Q1 2026MDAISpectral AI-$0.11N/AN/AN/A$4.13 millionN/A3/24/2026Q4 2025MDAISpectral AI-$0.1267$0.02+$0.1467$0.02$2.91 million$3.85 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBDMDBaird Medical InvestmentN/AN/AN/AN/AN/AMDAISpectral AIN/AN/AN/AN/AN/ARVPRetractable TechnologiesN/AN/AN/AN/AN/ASTSSSharps TechnologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBDMDBaird Medical InvestmentN/AN/AN/AMDAISpectral AIN/A0.940.90RVPRetractable Technologies0.018.575.92STSSSharps TechnologyN/A4.023.88Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBDMDBaird Medical Investment19.78%MDAISpectral AI67.08%RVPRetractable Technologies7.58%STSSSharps Technology17.17%Insider OwnershipCompanyInsider OwnershipBDMDBaird Medical Investment78.90%MDAISpectral AI30.70%RVPRetractable Technologies59.50%STSSSharps Technology1.22%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBDMDBaird Medical InvestmentN/A40.98 million8.65 millionN/AMDAISpectral AI8331.82 million22.05 millionNot OptionableRVPRetractable Technologies24029.94 million13.47 millionOptionableSTSSSharps Technology338.67 million38.19 millionNot OptionableRVP, STSS, BDMD, and MDAI HeadlinesRecent News About These CompaniesWall Street Zen Downgrades Sharps Technology (NASDAQ:STSS) to SellMay 2, 2026 | marketbeat.comSharps Technology, Inc. (NASDAQ:STSS) Sees Significant Increase in Short InterestApril 30, 2026 | marketbeat.comSharps Technology (NASDAQ:STSS) Stock Price Down 4.8% - Time to Sell?April 28, 2026 | marketbeat.comSharps Technology Reports 2025 Year-End Results and Highlights Continued Execution of Solana Treasury StrategyApril 7, 2026 | theglobeandmail.comSharps Technology, Inc. Reports Financial Results for 2025 with Over 2 Million SOL and Expanded Partnerships in the Solana EcosystemApril 6, 2026 | quiverquant.comQSharps Technology and The Tie Announce Strategic Collaboration to Advance Institutional Participation in the Solana EcosystemFebruary 25, 2026 | markets.businessinsider.comSharps Technology Appoints Interim Chief Financial Officer LevineFebruary 23, 2026 | tipranks.comHoldings Ltd Falconx Sells 239,588 Shares of Sharps Technology (NASDAQ:STSS) StockFebruary 14, 2026 | insidertrades.comSharps Technology and BitGo Announce Collaboration to Advance Solana Treasury StrategyFebruary 5, 2026 | globenewswire.comSharps Technology Inc: Sharps Technology Reports Strong Solana Staking IncomeJanuary 26, 2026 | finanznachrichten.deSharps Technology Reports Strong Solana Staking IncomeJanuary 26, 2026 | manilatimes.netMSaba Capital Management, L.P. Sells 12,182 Shares of Sharps Technology (NASDAQ:STSS) StockJanuary 21, 2026 | insidertrades.comSharps Technology Adopts Amended Bylaws and Committee ChartersJanuary 18, 2026 | theglobeandmail.comSharps Technology Advisor Lock-Up Supports Strategic RoadmapJanuary 16, 2026 | tipranks.comSharps Technology, Inc. Enters 90-Day Lock-Up Agreement with SOL Markets to Reinforce Strategic Alignment and ConfidenceJanuary 16, 2026 | quiverquant.comQSharps Technology Strengthens Market Confidence with Advisor Lock-Up AgreementJanuary 16, 2026 | globenewswire.comMajor Investor Shakes Up Sharps Technology With Notable Stock SaleJanuary 15, 2026 | tipranks.comSharps Technology expands relationship with Coinbase InstitutionalJanuary 14, 2026 | finance.yahoo.comSharps Technology Launches Solana Validator With CoinbaseJanuary 12, 2026 | ventureburn.comVSharps Technology and Coinbase Expand Relationship with Launch of Institutional-Grade Solana ValidatorJanuary 12, 2026 | markets.businessinsider.comSharps Technology director resigns over governance conflict concernsDecember 23, 2025 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeRVP, STSS, BDMD, and MDAI Company DescriptionsBaird Medical Investment NASDAQ:BDMD$1.85 -0.01 (-0.43%) As of 11:15 AM Eastern This is a fair market value price provided by Massive. Learn more.Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.Spectral AI NASDAQ:MDAI$2.26 +0.02 (+0.67%) As of 11:15 AM Eastern This is a fair market value price provided by Massive. Learn more.Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.Retractable Technologies NYSE:RVP$0.71 +0.00 (+0.16%) As of 11:15 AM Eastern This is a fair market value price provided by Massive. Learn more.Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.Sharps Technology NASDAQ:STSS$1.88 +0.01 (+0.59%) As of 11:14 AM Eastern This is a fair market value price provided by Massive. Learn more.Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Dutch Bros Q1 Earnings: The Newest Starbucks Rival Faces Its First Big Reality Check The AI Fear Around Datadog Stock May Have Been Completely Wrong Amprius Technologies Ups the Voltage on Forward Outlook Why Lam Research Still Looks Like a Buy After a 300% Rally Wells Fargo’s Comeback Is Real—But Not Risk-Free IonQ Just Posted a Breakout Quarter—But 1 Problem Remains SLB’s Tough Quarter Masks a Powerful Long-Term Shift Super Micro Surges Over 20% as Margins Soar, Sales Fall Short Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
